scispace - formally typeset
Search or ask a question
Institution

University of Udine

EducationUdine, Italy
About: University of Udine is a education organization based out in Udine, Italy. It is known for research contribution in the topics: Population & Large Hadron Collider. The organization has 6745 authors who have published 20530 publications receiving 669088 citations. The organization is also known as: Università degli Studi di Udine & Universita degli Studi di Udine.


Papers
More filters
Journal ArticleDOI
TL;DR: In this article, the effects of fluoxetine in comparison with other antidepressive agents for depression compared with tricyclics (TCAs), SSRIs, serotonin-noradrenaline reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and newer agents, and other conventional and unconventional agents were evaluated.
Abstract: Background Depression is common in primary care and is associated with marked personal, social and economic morbidity, thus creating significant demands on service providers. The antidepressant fluoxetine has been studied in many randomised controlled trials (RCTs) in comparison with other conventional and unconventional antidepressants. However, these studies have produced conflicting findings. Other systematic reviews have considered selective serotonin reuptake inhibitor (SSRIs) as a group which limits the applicability of the findings for fluoxetine alone. Therefore, this review intends to provide specific and clinically useful information regarding the effects of fluoxetine for depression compared with tricyclics (TCAs), SSRIs, serotonin-noradrenaline reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs) and newer agents, and other conventional and unconventional agents. Objectives To assess the effects of fluoxetine in comparison with all other antidepressive agents for depression in adult individuals with unipolar major depressive disorder. Search methods We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Review Group Controlled Trials Register (CCDANCTR) to 11 May 2012. This register includes relevant RCTs from the Cochrane Central Register of Controlled Trials (CENTRAL) (all years), MEDLINE (1950 to date), EMBASE (1974 to date) and PsycINFO (1967 to date). No language restriction was applied. Reference lists of relevant papers and previous systematic reviews were handsearched. The pharmaceutical company marketing fluoxetine and experts in this field were contacted for supplemental data. Selection criteria All RCTs comparing fluoxetine with any other AD (including non-conventional agents such as hypericum) for patients with unipolar major depressive disorder (regardless of the diagnostic criteria used) were included. For trials that had a cross-over design only results from the first randomisation period were considered. Data collection and analysis Data were independently extracted by two review authors using a standard form. Responders to treatment were calculated on an intention-to-treat basis: dropouts were always included in this analysis. When data on dropouts were carried forward and included in the efficacy evaluation, they were analysed according to the primary studies; when dropouts were excluded from any assessment in the primary studies, they were considered as treatment failures. Scores from continuous outcomes were analysed by including patients with a final assessment or with the last observation carried forward. Tolerability data were analysed by calculating the proportion of patients who failed to complete the study due to any causes and due to side effects or inefficacy. For dichotomous data, odds ratios (ORs) were calculated with 95% confidence intervals (CI) using the random-effects model. Continuous data were analysed using standardised mean differences (SMD) with 95% CI. Main results A total of 171 studies were included in the analysis (24,868 participants). The included studies were undertaken between 1984 and 2012. Studies had homogenous characteristics in terms of design, intervention and outcome measures. The assessment of quality with the risk of bias tool revealed that the great majority of them failed to report methodological details, like the method of random sequence generation, the allocation concealment and blinding. Moreover, most of the included studies were sponsored by drug companies, so the potential for overestimation of treatment effect due to sponsorship bias should be considered in interpreting the results. Fluoxetine was as effective as the TCAs when considered as a group both on a dichotomous outcome (reduction of at least 50% on the Hamilton Depression Scale) (OR 0.97, 95% CI 0.77 to 1.22, 24 RCTs, 2124 participants) and a continuous outcome (mean scores at the end of the trial or change score on depression measures) (SMD 0.03, 95% CI -0.07 to 0.14, 50 RCTs, 3393 participants). On a dichotomous outcome, fluoxetine was less effective than dothiepin or dosulepin (OR 2.13, 95% CI 1.08 to 4.20; number needed to treat (NNT) = 6, 95% CI 3 to 50, 2 RCTs, 144 participants), sertraline (OR 1.37, 95% CI 1.08 to 1.74; NNT = 13, 95% CI 7 to 58, 6 RCTs, 1188 participants), mirtazapine (OR 1.46, 95% CI 1.04 to 2.04; NNT = 12, 95% CI 6 to 134, 4 RCTs, 600 participants) and venlafaxine (OR 1.29, 95% CI 1.10 to 1.51; NNT = 11, 95% CI 8 to 16, 12 RCTs, 3387 participants). On a continuous outcome, fluoxetine was more effective than ABT-200 (SMD -1.85, 95% CI -2.25 to -1.45, 1 RCT, 141 participants) and milnacipran (SMD -0.36, 95% CI -0.63 to -0.08, 2 RCTs, 213 participants); conversely, it was less effective than venlafaxine (SMD 0.10, 95% CI 0 to 0.19, 13 RCTs, 3097 participants). Fluoxetine was better tolerated than TCAs considered as a group (total dropout OR 0.79, 95% CI 0.65 to 0.96; NNT = 20, 95% CI 13 to 48, 49 RCTs, 4194 participants) and was better tolerated in comparison with individual ADs, in particular amitriptyline (total dropout OR 0.62, 95% CI 0.46 to 0.85; NNT = 13, 95% CI 8 to 39, 18 RCTs, 1089 participants), and among the newer ADs ABT-200 (total dropout OR 0.18, 95% CI 0.08 to 0.39; NNT = 3, 95% CI 2 to 5, 1 RCT, 144 participants), pramipexole (total dropout OR 0.12, 95% CI 0.03 to 0.42, NNT = 3, 95% CI 2 to 5, 1 RCT, 105 participants), and reboxetine (total dropout OR 0.60, 95% CI 0.44 to 0.82, NNT = 9, 95% CI 6 to 24, 4 RCTs, 764 participants). Authors' conclusions The present study detected differences in terms of efficacy and tolerability between fluoxetine and certain ADs, but the clinical meaning of these differences is uncertain. Moreover, the assessment of quality with the risk of bias tool showed that the great majority of included studies failed to report details on methodological procedures. Of consequence, no definitive implications can be drawn from the studies' results. The better efficacy profile of sertraline and venlafaxine (and possibly other ADs) over fluoxetine may be clinically meaningful, as already suggested by other systematic reviews. In addition to efficacy data, treatment decisions should also be based on considerations of drug toxicity, patient acceptability and cost.

203 citations

Journal ArticleDOI
Morad Aaboud, Georges Aad1, Brad Abbott2, Ovsat Abdinov3  +2981 moreInstitutions (220)
TL;DR: In this article, a search was performed for resonant and non-resonant Higgs boson pair production in the $ \upgamma \ upgamma b\overline{b} $ final state.
Abstract: A search is performed for resonant and non-resonant Higgs boson pair production in the $ \upgamma \upgamma b\overline{b} $ final state. The data set used corresponds to an integrated luminosity of 36.1 fb$^{−1}$ of proton-proton collisions at a centre-of-mass energy of 13 TeV recorded by the ATLAS detector at the CERN Large Hadron Collider. No significant excess relative to the Standard Model expectation is observed. The observed limit on the non-resonant Higgs boson pair cross-section is 0.73 pb at 95% confidence level. This observed limit is equivalent to 22 times the predicted Standard Model cross-section. The Higgs boson self-coupling (κ$_{λ}$ = λ$_{HHH}$/λ$_{HHH}^{SM}$ ) is constrained at 95% confidence level to −8.2 < κ$_{λ}$ < 13.2. For resonant Higgs boson pair production through $ X\to HH\to \upgamma \upgamma b\overline{b} $ , the limit is presented, using the narrow-width approximation, as a function of m$_{X}$ in the range 260 GeV < m$_{X}$ < 1000 GeV. The observed limits range from 1.1 pb to 0.12 pb over this mass range.

202 citations

Journal ArticleDOI
TL;DR: A progression model of facial AK developing into IEC and invasive SCC is proposed based on the findings of a retrospective analysis of dermoscopic images of histopathologically diagnosed keratinocyte skin cancer.
Abstract: Background Little is known about the dermoscopic features of keratinocyte skin cancer. Objective We sought to determine the dermoscopic features of facial actinic keratosis (AK), intraepidermal carcinoma (IEC), moderately to poorly differentiated invasive squamous cell carcinoma (SCC), and well-differentiated SCC of the keratoacanthoma type. Methods This was a retrospective analysis of dermoscopic images of histopathologically diagnosed keratinocyte skin cancer. Results A total of 243 (70 AK, 71 IEC, 78 SCC, and 24 keratoacanthomas) tumors of the face from 243 patients (mean age: 71.1 years; range: 44-94 years) were analyzed. The majority of patients had a fair skin type, history of melanoma or nonmelanoma skin cancer, and multiple AK. A red pseudonetwork was significantly associated with AK ( P P P Limitations The retrospective design of our study and the lack of assessment of sensitivity and specificity of the dermoscopic criteria are limitations. Conclusions Based on our findings we propose a progression model of facial AK developing into IEC and invasive SCC.

202 citations

Journal ArticleDOI
TL;DR: In this paper, the influence of Pb, Zn, and Tl on microbial biomass survival and activity during a laboratory incubation of soil was studied, and it was shown that the microbial biomass C decreased sharply in soil contaminated with Zn and Tls, whereas the addition of PB did not have any significant inhibitory effect on the level of microbial biomassC.
Abstract: In this work we studied the influence of Pb, Zn, and Tl on microbial biomass survival and activity during a laboratory incubation of soil. In comparison to uncontaminated soil, the microbial biomass C decreased sharply in soil contaminated with Zn and Tl, whereas the addition of Pb did not have any significant inhibitory effect on the level of microbial biomass C. Zn displayed the greatest biocidal effect, confirmed by the measurement of the death rate quotient (q D). The microbial activity, measured as CO2 evolution, increased significantly in contaminated soils, emphasizing the need of living organisms to expend more energy to survive. The greater demand for energy by microorganisms in order to cope with the toxicity of pollutants was also confirmed by measurement of the metabolic quotient (q CO2). In order to determine whether soil microorganisms affect the bioavailability of these metals through their mobilization and release, we studied the relationships between available Pb, Zn, and Tl, and microbial biomass C. The water-soluble fraction of Tl, available Tl, and Zn, and microbial biomass C were related significantly, but not Pb.

202 citations

Journal ArticleDOI
Georges Aad1, Brad Abbott2, Jalal Abdallah, A. A. Abdelalim3  +3042 moreInstitutions (179)
TL;DR: In this paper, the cross-section and fraction of J/psi mesons produced in B-hadron decays are measured in proton proton collisions at root s = 7 TeV with the ATLAS detector at the LHC, using 2.3 pb(-1) of integrated luminosity.

202 citations


Authors

Showing all 6857 results

NameH-indexPapersCitations
M.-Marsel Mesulam15055890772
Francesco Longo14274589859
Georges Aad135112188811
Bobby Samir Acharya1331121100545
G. Della Ricca133159892678
Marina Cobal132107885437
Fernando Barreiro130108283413
Saverio D'Auria129114283684
Jean-Francois Grivaz128132297758
Evgeny Starchenko12886475913
Muhammad Alhroob12788071982
Michele Pinamonti12684669328
Reisaburo Tanaka12696769849
Kerim Suruliz12679569456
Kate Shaw12584170087
Network Information
Related Institutions (5)
University of Bologna
115.1K papers, 3.4M citations

96% related

University of Padua
114.8K papers, 3.6M citations

96% related

University of Milan
139.7K papers, 4.6M citations

95% related

University of Turin
77.9K papers, 2.4M citations

95% related

Sapienza University of Rome
155.4K papers, 4.3M citations

95% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202350
2022142
20211,338
20201,388
20191,223
20181,102